Choice of antimuscarinic agents for overactive bladder in the older patient: focus on darifenacin
Bilal Chughtai1, Robert Levin2, Elise De11Albany Medical College, Division of Urology; 2Albany College of Pharmacy and Stratton VAMC, Albany, NY, USAAbstract: Overactive bladder (OAB) is a difficult condition to live with and is very costly tothe community. OAB affects 16% of the adult population an...
Enregistré dans:
Auteurs principaux: | Bilal Chughtai, Robert Levin, Elise De |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Dove Medical Press
2008
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/c7c20afaace947c19801ad9d191f0c5a |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
The safety and efficacy of tolterodine extended release in the treatment of overactive bladder in the elderly
par: Danny Ulahannan, et autres
Publié: (2009) -
Acupuncture for Treatment of Overactive Bladder
par: Maryam Hosseini, et autres
Publié: (2021) -
Mirabegron in the Treatment of Overactive Bladder: Safety and Efficacy in the Very Elderly Patient
par: Makhani A, et autres
Publié: (2020) -
Overactive bladder: strategies to ensure treatment compliance and adherence
par: Dhaliwal P, et autres
Publié: (2016) -
Evaluation of Silodosin and Pelvic Floor Muscle Training in Men with Benign Prostatic Hyperplasia and Overactive Bladder (Silodosing) Study Protocol (Spirit Compliant)
par: Magdalena Hagovska, et autres
Publié: (2021)